Peregrine Pharma (PPHM) Posts Q1 Loss of $0.14, Misses Views
Peregrine Pharmaceuticals (Nasdaq: PPHM) reports Q1 loss of $0.14, versus the analyst estimate of ($0.11). Revenue for the quarter was $3.21 million, which compares to the estimate of $5.83 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Twilio (TWLO) Files for $100M IPO
- Splunk (SPLK) Reports In-Line Q1 EPS, Raises FY Rev. Guidance
- Abercrombie & Fitch (ANF) Misses Q1 EPS by 12c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!